Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine
Open Access
- 1 September 2000
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (6) , 715-718
- https://doi.org/10.1054/bjoc.2000.1314
Abstract
Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred.Keywords
This publication has 20 references indexed in Scilit:
- Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.1998
- Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-RoussyTumori Journal, 1990
- Long-term Course of Patients with Persistent Hypercalcitoninemia After Apparent Curative Primary Surgery for Medullary Thyroid CarcinomaAnnals of Surgery, 1990
- Metastatic medullary thyroid carcinoma: Complete response to combination chemotherapy with dacarbazine and 5-fluorouracilCancer, 1988
- A Phase II Trial of Streptozotocin and Adriamycin in Advanced APUD TumorsAmerican Journal of Clinical Oncology, 1988
- Chemotherapy for thyroid cancerRadiotherapy and Oncology, 1987
- PHASE-II EVALUATION OF DOXORUBICIN PLUS CISPLATIN IN ADVANCED THYROID-CANCER - A SOUTHEASTERN-CANCER-STUDY-GROUP TRIAL1986
- A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinomaCancer, 1985
- External radiotherapy in thyroid cancersCancer, 1985
- Reporting results of cancer treatmentCancer, 1981